Wnt Pathway Modulation via Small Molecule Compounds
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies lack effective solutions for modulating the Wnt pathway, which is critical in regulating stem cell behavior and is implicated in various diseases such as cancer and heart disease, due to its role in cell proliferation and differentiation.
Innovation Solution
Development of novel pharmaceutical compositions, specifically compounds with defined structures (e.g., Formula (IA) and (IB)), that can effectively reduce Wnt-mediated effects and treat cancer by targeting the Wnt pathway.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current therapies are used, then treatment of cancer and Wnt-mediated diseases is provided, but effective modulation of the Wnt pathway is not achieved
Solution Approach 1:
The patent employs small molecule compounds as intermediaries that specifically bind to and modulate the Wnt pathway components (such as Frizzled receptors or beta-catenin), enabling effective therapeutic modulation without directly targeting the entire pathway complex. These compounds act as molecular mediators between the administered therapy and the Wnt signaling components.
Solution Approach 2:
The invention utilizes compounds that induce parameter changes in the Wnt pathway by altering the conformational state, binding affinity, or activity level of key pathway components. The small molecules modify physical-chemical parameters of the target proteins to achieve desired therapeutic effects on stem cell behavior and cancer cell proliferation.
2Ease of manufacture
If no specific Wnt pathway modulators are available, then general cancer treatments can be applied, but targeted therapy for Wnt-mediated effects is not possible
Solution Approach 1:
The patent segments the broad cancer treatment approach into targeted Wnt pathway modulation by developing specific small molecule compounds that act on discrete components of the Wnt signaling pathway. This segmentation allows for precise targeting of Wnt-mediated effects while maintaining the feasibility of pharmaceutical manufacturing and clinical application.
Data Source
AI summary
Provided herein are novel compounds, pharmaceutical compositions for use, inter alia, in methods of reducing Wnt-mediated effects and treating cancer.